https://www.selleckchem.com/products/sf2312.html
88, 95% CI 3.69-24.9, p less then 0.0001], fibromyalgia (OR 4.43, 95% CI 2.04-10.1, p=0.0002), history of irritable bowel syndrome (OR 5.01, 95% CI 2.31-11.2, p less then 0.0001), and gastroesophageal reflux disease (OR 3.33, 95% CI 1.55-7.44, p=0.002) were more likely to be diagnosed with GI dysmotility. On multivariable analysis, only POTS (OR 5.74, 95% CI 2.25-16.7, p=0.0005) was significantly associated with an increased likelihood of GI dysmotility. Conclusions This study suggests that GI symptoms are relatively common among patient